Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-05
2010-06-22
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S450000, C540S476000, C540S479000
Reexamination Certificate
active
07741315
ABSTRACT:
Tricyclic compounds of Formula (I) are inhibitors of HIV integrase and inhibitors of HIV replication: wherein bond a, ring A, R1, R2and R3are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
REFERENCES:
patent: 6262055 (2001-07-01), Young et al.
patent: 6306891 (2001-10-01), Selnick et al.
patent: 6380249 (2002-04-01), Young et al.
patent: 6841558 (2005-01-01), Anthony et al.
patent: 6919351 (2005-07-01), Anthony et al.
patent: 6921759 (2005-07-01), Anthony et al.
patent: 7109186 (2006-09-01), Walker et al.
patent: 7169780 (2007-01-01), Crescenzi et al.
patent: 7211572 (2007-05-01), Miyazaki et al.
patent: 7217713 (2007-05-01), Crescenzi et al.
patent: 7232819 (2007-06-01), Di Francesco et al.
patent: 7279487 (2007-10-01), Egbertson et al.
patent: 7459452 (2008-12-01), Di Francesco et al.
patent: 2003/0055071 (2003-03-01), Anthony et al.
patent: 2003/0229079 (2003-12-01), Payne et al.
patent: 2004/0229909 (2004-11-01), Kiyama et al.
patent: 2005/0010048 (2005-01-01), Zhuang et al.
patent: 2007/0083045 (2007-04-01), Di Francesco et al.
patent: 2007/0123524 (2007-05-01), Crescenzi et al.
patent: 2007/0161639 (2007-07-01), Jones et al.
patent: 2007/0179196 (2007-08-01), Han et al.
patent: 2008/0139579 (2008-06-01), Morrissette et al.
patent: WO 2005/086700 (2005-11-01), None
patent: WO 2006/116764 (2006-11-01), None
Pearl, L. et al. “A structural model for the retroviral proteases”, Nature, 1987, vol. 329, pp. 351-354.
Power, M. et al. “Nucleotide Sequence of SRV-1, a Type D Simian Acquired Immune Deficiency Syndrome Retrovirus”, Science, 1986, vol. 231, pp. 1567-1572.
Ratner, L. et al. “Complete nucleotide sequence of the AIDS virus, HTLV-III”, Nature, 1985, vol. 313, pp. 277-284.
Toh, H. et al. “Close structural resemblance between putative polymerase of a Drosophila transposable genetic element 17.6 and pol gene product of Moloney murine leukaemia virus”, The EMBO Journal, 1985, vol. 4, pp. 1267-1272.
U.S. Appl. No. 10/591,914 Office Action dated Apr. 20, 2009 and Amendments filed May 8 and 11, 2009.
Isaacs Richard C. A.
Payne Linda S.
Pracitto Richard
Vacca Joseph P.
Wai John S.
Heber Sheldon O.
Merck Sharp & Dohme Corp.
Walton Kenneth R.
Ward Paul V.
Wilson James O.
LandOfFree
HIV integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HIV integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV integrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4191157